bit.bio
Series BCambridge, UKNov 2021
bit.bio raised €89M in a Series B round in Nov 2021. The company is based in Cambridge, UK. Investors in the round: ARCH Venture Partners, Charles River Laboratories, Foresite Capital and 4 others. Data as of 4 Nov 2026.
Amount raised
€89M
€88,954,141
Native amount
103,000,000 USD
Stage
Series B
series b
Investors
7
Provenance & confidence
High confidenceAmount
103,000,000 USD
ECB-at-date → €89M · rate 1.1579 on 2021-11-08
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
7 namedARCH Venture PartnersCharles River LaboratoriesForesite CapitalMetaplanetPuhua CapitalResilienceTencent
Date
Nov 2021
Round type
series b
Amount (EUR)
€89M
Other rounds
same companyRelated news
- U.K.-based https://t.co/G4TfNV0VQM secures €89.1M to expedite gene engineering technology to fight diseasessiliconcanals.com · 2021-11